Metastatic Colorectal Cancer in the Era of Personalized Medicine: A More Tailored Approach to Systemic Therapy

Colorectal cancer is the second most common malignancy diagnosed in Canada. Despite declining incidence and mortality rates in recent years, there is still a significant number of cases that are metastatic at presentation. Fluoropyrimidine-based chemotherapy was the backbone of colorectal cancer tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Irene S., Cheung, Winson Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241232/
https://www.ncbi.nlm.nih.gov/pubmed/30519549
http://dx.doi.org/10.1155/2018/9450754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241232/
https://www.ncbi.nlm.nih.gov/pubmed/30519549
http://dx.doi.org/10.1155/2018/9450754

Ejemplares similares